Destiny 2’s Most Overpowered Weapon Still Ruining Trials of Osiris

by

As a dedicated fan, I can’t help but notice that the standout weapon from Destiny 2’s Episode Heresy – despite taking a double hit from nerfs – remains unstoppable in Trials of Osiris and broader PvP scenes.

Bungie’s March 11 patch to introduce Heresy Act 2 also significantly nerfed Redrix’s Estoc and the entire Lightweight Pulse archetype to which it belongs, reducing body shot and critical hit damage across the board while targeting Estoc with specific stat reductions.

On paper, the adjustments looked extensive enough to give other primary weapons a look-in for PvP, but no such luck. Redrix’s Estoc is still king of The Crucible and continues its streak of warping the meta around it, especially in Trials of Osiris.

Redrix’s Estoc survives nerfs to dominate the meta

Per DestinyTrialsReport, which tracks individual weapon kills across all platforms for each iteration of the weekly four-day event, Redrix’s Estoc accounted for 16% of all kills in the activity, a measly reduction of 1% over the previous week.

Humorously, the Lightweight Pulse Rifle nerfs curbed their prevalence elsewhere. Outbreak Perfected suffered a harsh drop in kills and BxR-55 Battler disappeared from the top 10 entirely. Still, Estoc wracked up more than triple the number of kills than Tommy’s Matchbook – a popular Exotic for Hunters when paired with Radiant Dance Machines.

What happens from here? Well, Bungie’s track record of combating meta anomalies is nothing if not excellent. Nothing has been confirmed yet but a second balance pass is likely. The issue here, however, is that any further nerfs to Lightweight Pulse Rifles will unfairly neuter the entire archetype – Estoc needs to be directly targeted.

Looking to change up your PvP and PvE loadouts? Check out god rolls for Exalted Truth and Crimil’s Dagger as well as our tier list of all the best weapons to use in The Crucible as of Heresy Act 2.

Read More

2025-03-18 15:52